0.23
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ACC Aviation Holdings
Its shares trade under the ticker CAVG. It has been listed since 29 July 1999. In the fiscal year to 31 December 2025, it reported revenue of $156,000 and net income of $16,278. At that date it held total assets of $28,656 and shareholders' equity of $20,577.
ACC Aviation Holdings Ltd. outsources all professional services to third parties. The firm focuses on the development and production of commercially-viable cannabis powder-based drugs for medical uses. Cannapowder Inc's research and development programs main objective is to identify active pharmaceutical ingredient, such as cannabidiol (CBD), cannabinol (CBN) and tetrahydrocannabidiol (THC). The active ingredients interact with body receptors and help in controlling bodily reactions such as inflammation and pain. The firm's objective is to establish and operate several production facilities, each located in separate territories. The firm operates through its subsidiary, Canna Powder Israel.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 29 Jul 1999
Leadership
Pay as last reported
- Mr. Shai CohenChief Executive Officer, Director, since 2019
- Mr. Aharon LevinasChief Technology Officer, Director, since 2005$457,434
- Mr. Michael Ben-AriDirector
- Mr. Tamir LevinasDirector
- Mr. Guy MosheDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ACC Aviation Holdings Ltd focuses on cannabis powder-based drugs for medical use with CBD, CBN, and THC active ingredients.
- Canna Powder Israel operates as a subsidiary for production facilities in separate territories.
- The company outsources all professional services to third parties for efficient resource allocation.
Weaknesses
- The company relies on third-party outsourcing for all professional services which may lead to dependency.
- ACC Aviation Holdings Ltd has no direct production facilities and depends on subsidiaries for operations.
- Cannapowder Inc's R&D focuses on specific active ingredients without broader pharmaceutical applications.
Opportunities
- Expanding production facilities in multiple territories can increase market reach for cannabis-based medical drugs.
- Growing demand for medical cannabis products in the Health Care sector presents a significant opportunity.
- The use of CBD, CBN, and THC in pain and inflammation control can attract new medical applications.
Threats
- Regulatory challenges in the Pharmaceuticals industry may restrict the use of cannabis-based drugs.
- Competition from established pharmaceutical companies in the Health Care sector could impact market share.
- Legal restrictions on cannabis use in certain countries may limit global expansion.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.